2 Results

Sort by: Published date Updated Date Title ID Descending Ascending

Glycoprotein Tetramer for Identifying Antigen-specific B Cells Application Ectodomain of viral glycoprotein tetramers detects antigen-specific memory B Cells. Key Benefits Viral glycoprotein tetramers detect antigen-specific memory B cells in the peripheral blood and tissues. Hepatitis C virus E2 protein triggers immune response, which may yield an effective vaccine against hepatitis C virus. Market Summary Hepatitis... Published: 4/23/2024       Contributor(s): Arash Grakoui, Joseph Marcotrigiano

Hepatitis C Virus (HCV) Mutants for Vaccine Development Application Mutated HCV as vaccine antigen. Key Benefits Non-infectious live HCV mutants which disrupt viral entry into healthy cells. No current vaccine for prevention of HCV infection. Market Summary While 15-20% of HCV patients are able to clear the infection without treatment, the majority of HCV patients become chronically infected leading... Published: 4/23/2024       Contributor(s): Arash Grakoui